AB Sciex has announced that it has achieved ISO 13485 certification for its quality management system.
AB Sciex has announced that it has achieved ISO 13485 certification for its quality management system. This certification requires a manufacturer to demonstrate a compliant quality management system suitable for the design and manufacturing of medical devices. It covers the manufacturing facility in Singapore and the R&D design centre in Toronto. With this, AB Sciex is coming closer to complying with European regulatory standards for a device to be cleared for use in the clinic.
Rainer Blair, President of AB Sciex, commented, “AB Sciex is taking the necessary steps to be compliant with regulatory requirements that govern entry into clinical diagnostics. Achieving the ISO 13485 certification is an important measure toward realizing the vision of our LC–MS–MS systems to be cleared for use in clinics.”
The company currently manufactures and sells LC–MS–MS systems for research purposes only.
For more information please visit ref="http://www.absciex.com">www.absciex.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.